Cargando…

Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.

Risk of second primary malignancy was assessed in follow-up to June 1991 of 1039 patients first treated for Hodgkin's disease at the Royal Marsden Hospital during 1963-91. A total of 77 second malignancies occurred. There were significantly raised risks of stomach [standardized incidence ratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swerdlow, A. J., Barber, J. A., Horwich, A., Cunningham, D., Milan, S., Omar, R. Z.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222705/ https://www.ncbi.nlm.nih.gov/pubmed/9000608

Ejemplares similares

Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment.
por: Taylor, A. E., et al.
Publicado: (1995)

Treatment of Epithelioid Sarcoma at the Royal Marsden Hospital
por: Livi, L., et al.
Publicado: (2003)

Second primary breast cancer after Hodgkin's disease
por: Horwich, A, et al.
Publicado: (2004)

The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil.
por: Crawley, C., et al.
Publicado: (1998)

Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital
por: Cunningham, Niamh, et al.
Publicado: (2022)

Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience
por: Maruzzo, Marco, et al.
Publicado: (2015)

Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience
por: Khan, Khurum, et al.
Publicado: (2015)

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
por: Arkenau, H-T, et al.
Publicado: (2008)

Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience
por: Olmos, D, et al.
Publicado: (2008)

Dr. Marsden
Publicado: (1836)

Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
por: Bamias, A., et al.
Publicado: (1995)

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
por: Tirelli, U
Publicado: (2008)

Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience
por: Waddell, T, et al.
Publicado: (2011)

Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital
por: Thanopoulou, Eirini, et al.
Publicado: (2015)

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
por: Kote-Jarai, Z, et al.
Publicado: (2000)

The practical aspects of propofol target controlled infusion for magnetic resonance imaging in children: An audit from the Royal Marsden Hospital
por: Haberman, Emily, et al.
Publicado: (2013)

Dr. Marsden’s Plan of Quarantine
Publicado: (1866)

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2020)

Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2019)

Geometry, mechanics, and dynamics: the legacy of Jerry Marsden
por: Chang, Dong, et al.
Publicado: (2015)

The stretch reflex and the contributions of C David Marsden
por: Bhattacharyya, Kalyan B.
Publicado: (2017)

Student’s guide to calculus by J. Marsden and A. Weinstein
por: Soon, Frederick H
Publicado: (1985)

John Marsden's will: the Hornby estate case 1780–1840
por: Watson, Katherine D
Publicado: (2000)

Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations.
por: Swerdlow, A. J., et al.
Publicado: (1996)

Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital
por: Bianchini, Diletta, et al.
Publicado: (2017)

Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens.
por: Ingram, L., et al.
Publicado: (1987)

The Most Influential Scientist in the Development of Medical informatics (10): Marsden S. Blois
por: Masic, Izet
Publicado: (2016)

Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy.
por: Swerdlow, A. J., et al.
Publicado: (1993)

Changing patterns of relapse in Hodgkin's disease.
por: Duchesne, G., et al.
Publicado: (1989)

Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era
por: LeMieux, Melissa H, et al.
Publicado: (2015)

Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience
por: Shbib Dabaja, Bouthaina, et al.
Publicado: (2022)

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors
por: Cooke, R, et al.
Publicado: (2013)

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
por: Andersson, A, et al.
Publicado: (2008)

Risk and outcome of second primary malignancy in patients with classical Hodgkin lymphoma
por: Wang, Fan
Publicado: (2022)

Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
por: Horwich, A, et al.
Publicado: (2014)

Additional Cases Treated at the Royal Maternity Hospital
por: Bell, Charles
Publicado: (1872)

Second malignancies in Hodgkin's disease: A review of the literature and report of a case with a secondary Lennert's lymphoma
por: Norval, Ernst JG, et al.
Publicado: (2014)

Royal College of Surgeons—Second Conversazione
Publicado: (1856)

Racial/Ethnic Disparities on the Risk of Second Malignant Neoplasm Among Hodgkin Lymphoma Survivors
por: Xiao, Han, et al.
Publicado: (2022)

Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival.
por: Eeles, R. A., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_gr71m8qd794vg8djmva81547bp